Browsing Tag
United States FDA
1 post
Lupin launches first U.S. long-acting injectable from Nanomi—what does it mean for its specialty drug future?
Lupin’s risperidone injectable wins FDA approval with 180-day CGT exclusivity—marking the first major milestone for its Nanomi long-acting injectable platform.